Emergent Biosolutions Inc (EBS)
Depreciation & Amortization
$24.00M
Quarterly · Period ending: · USD
EBS Depreciation & Amortization
Latest reported$24.00Mperiod ending
Latest reported$24.00Mperiod ending
EBS Quarterly Depreciation & Amortization ($1.45M → $24.00M)
Quarterly Depreciation & Amortization
High-resolution chart · PNG
EBS depreciation & amortization history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Depreciation & Amortization (USD) |
|---|---|
| 24,000,000 | |
| 23,500,000 | |
| 23,500,000 | |
| 23,400,000 | |
| 23,500,000 | |
| 25,400,000 | |
| 26,000,000 | |
| 26,400,000 | |
| 28,500,000 | |
| 27,900,000 | |
| 29,600,000 | |
| 28,000,000 | |
| 32,900,000 | |
| 34,600,000 | |
| 35,600,000 | |
| 32,200,000 | |
| 44,500,000 | |
| 30,900,000 | |
| 29,200,000 | |
| 32,700,000 | |
| 33,200,000 | |
| 28,700,000 | |
| 28,900,000 | |
| 28,800,000 | |
| 28,600,000 | |
| 28,200,000 | |
| 27,900,000 | |
| 27,700,000 | |
| 28,500,000 | |
| 26,600,000 | |
| 25,094,000 | |
| 12,400,000 | |
| 12,400,000 | |
| 12,300,000 | |
| 12,673,000 | |
| 9,802,000 | |
| 9,931,000 | |
| 10,166,000 | |
| 10,074,000 | |
| 10,385,000 | |
| 8,930,000 | |
| 8,840,000 | |
| 9,476,000 | |
| 8,561,000 | |
| 8,766,000 | |
| 8,532,000 | |
| 8,167,000 | |
| 8,992,000 | |
| 8,459,000 | |
| 6,835,000 | |
| 5,411,000 | |
| 5,175,000 | |
| 4,209,000 | |
| 4,163,000 | |
| 3,518,000 | |
| 2,770,000 | |
| 2,536,000 | |
| 2,373,000 | |
| 2,429,000 | |
| 2,412,000 | |
| 2,279,000 | |
| 2,235,000 | |
| 1,970,000 | |
| 1,374,000 | |
| 1,350,000 | |
| 1,296,000 | |
| 1,322,000 | |
| 1,170,000 | |
| 1,245,000 | |
| 1,262,000 | |
| 1,417,000 | |
| 1,285,000 | |
| 1,181,000 | |
| 1,081,000 | |
| 1,220,000 | |
| 1,265,000 | |
| 1,134,000 | |
| 1,198,000 | |
| 1,450,000 |